Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 10
Submit an article Journal homepage
380
Views
16
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy

Efstathios KastritisDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceCorrespondence[email protected]
,
Pelagia MeleaDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
,
Tina BagratuniDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
,
Ioannis MelakopoulosDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
,
Maria GavriatopoulouDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
,
Maria RoussouDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
,
Magdalini MigkouDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
,
Evangelos Eleutherakis-PapaiakovouDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
,
Evangelos TerposDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
&
Meletios A. DimopoulosDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
 show all
Pages 2304-2309 | Received 30 Nov 2016, Accepted 22 Feb 2017, Published online: 11 Jun 2017

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Melody Becnel & Elisabet Esteve Manasanch. (2017) Myeloma patients: genes increase risk for osteonecrosis of the jaw. Leukemia & Lymphoma 58:10, pages 2271-2272.
Read now

Articles from other publishers (15)

Jung Sun Kim, Jin Woo Kim, Jeong Yee, Sun Jong Kim, Jee Eun Chung & Hye Sun Gwak. (2023) Interactive Associations between PPARγ and PPARGC1A and Bisphosphonate-Related Osteonecrosis of the Jaw in Patients with Osteoporosis. Pharmaceuticals 16:7, pages 1035.
Crossref
Aruche Hamid, Steven Thomas, Christopher Bell & Mark Gormley. (2023) Case series of medication-related osteonecrosis of the jaw (MRONJ) patients prescribed a drug holiday. British Journal of Oral and Maxillofacial Surgery 61:3, pages 227-232.
Crossref
А.А. Кабанова, С.А. Кабанова, К.С. Воднев & М.А. Леута. (2023) Стоматологическая помощь пациентам с медикаментозным остеонекрозом челюстей. Dentist. Minsk:1 (48), pages 36-41.
Crossref
Roberto Sacco, Sergio Olate, Monica Diuana Calasans-Maia, Nicola Sacco, Alessandro Acocella, Carlos Fernando De Almeida Barros Mourão, Vittorio Moraschini, Oladapo Akintola, Raphael Capelli Guerra & Julian Yates. (2022) A Comprehensive Quality Meta-Review of Genetic and Pharmacogenomic Aspects of Medication-Related Osteonecrosis of The Jaw (MRONJ). Applied Sciences 12:23, pages 12289.
Crossref
Xin Shen, Weiwen Zhu, Ping Zhang, Yu Fu, Jie Cheng, Laikui Liu, Rongyao Xu & Hongbing Jiang. (2022) Macrophage miR-149-5p induction is a key driver and therapeutic target for BRONJ. JCI Insight 7:16.
Crossref
Salvatore L. Ruggiero, Thomas B. Dodson, Tara Aghaloo, Eric R. Carlson, Brent B. Ward & Deepak Kademani. (2022) American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update. Journal of Oral and Maxillofacial Surgery 80:5, pages 920-943.
Crossref
Catherine Van Poznak, Evan L. Reynolds, Cherry L. Estilo, Mimi Hu, Bryan Paul Schneider, Daniel L. Hertz, Christina Gersch, Jacklyn Thibert, Dafydd Thomas, Mousumi Banerjee, James M. Rae & Daniel F. Hayes. (2020) Osteonecrosis of the jaw risk factors in bisphosphonate‐treated patients with metastatic cancer. Oral Diseases 28:1, pages 193-201.
Crossref
Yasser El Miedany. 2022. New Horizons in Osteoporosis Management. New Horizons in Osteoporosis Management 575 591 .
Rogério Jardim Caldas, Héliton Spíndola Antunes, Camila de Oliveira Rodini Pegoraro, Fábio Ribeiro Guedes & Paulo Sérgio da Silva Santos. (2021) Oral health condition in cancer patients under bisphosphonate therapy. Supportive Care in Cancer 29:12, pages 7687-7694.
Crossref
Zhiqiang Feng, Jingang An & Yi Zhang. (2021) Factors Influencing Severity of Medication-Related Osteonecrosis of the Jaw: A Retrospective Study. Journal of Oral and Maxillofacial Surgery 79:8, pages 1683-1688.
Crossref
Tomoya Soma, Ryotaro Iwasaki, Yuiko Sato, Tami Kobayashi, Satoshi Nakamura, Yosuke Kaneko, Eri Ito, Hiroyuki Okada, Hisato Watanabe, Kana Miyamoto, Morio Matsumoto, Masaya Nakamura, Seiji Asoda, Hiromasa Kawana, Taneaki Nakagawa & Takeshi Miyamoto. (2020) Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw. Journal of Bone and Mineral Metabolism 39:3, pages 372-384.
Crossref
Z. Guo, W. Cui, L. Que, C. Li, X. Tang & J. Liu. (2020) Pharmacogenetics of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis. International Journal of Oral and Maxillofacial Surgery 49:3, pages 298-309.
Crossref
Kye Hwa Lee, Su-Hwan Kim, Chang Hyen Kim, Byung Joo Min, Grace Juyun Kim, Younggyun Lim, Hun-Sung Kim, Kang-Min Ahn & Ju Han Kim. (2019) Identifying genetic variants underlying medication-induced osteonecrosis of the jaw in cancer and osteoporosis: a case control study. Journal of Translational Medicine 17:1.
Crossref
Guang Yang, Sonal Singh, Yiqing Chen, Issam S. Hamadeh, Taimour Langaee, Caitrin W. McDonough, L. Shannon Holliday, Jatinder K. Lamba, Jan S. Moreb, Joseph Katz & Yan Gong. (2019) Pharmacogenomics of osteonecrosis of the jaw. Bone 124, pages 75-82.
Crossref
Rahul Naithani, Tulika Seth, Nikhil Tandon, Jagdish Chandra, V. P. Choudhry, H. Pati & Renu Saxena. (2018) Zoledronic Acid for Treatment of Low Bone Mineral Density in Patients with Beta Thalassemia Major. Indian Journal of Hematology and Blood Transfusion 34:4, pages 648-652.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.